{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:27:30Z","timestamp":1789644450232,"version":"4.0.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cooperative Agreement Number 5","award":["NU50CK000574"],"award-info":[{"award-number":["NU50CK000574"]}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteoarticular infections (OAIs) are commonly treated with prolonged intravenous (IV) antimicrobials. The Oral versus Intravenous Antibiotics for Bone and Joint Infection (OVIVA) trial demonstrated that oral (PO) antibiotics are noninferior to IV antibiotics in the treatment of OAIs. We surveyed infectious disease (ID) physicians about their use of PO antibiotics in the treatment of OAIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An Emerging Infection Network survey with 9 questions regarding antibiotic prescribing for the treatment of OAIs was sent to 1475 North American ID physicians. The questions were mostly multiple choice and focused on the use of definitive oral antibiotic therapy (defined as oral switch within 2 weeks of starting antibiotics) and chronic suppressive antibiotic therapy (SAT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 413 physicians who reported treating OAIs, 91% used oral antibiotics at least sometimes and 31% used them as definitive therapy, most often for diabetic foot osteomyelitis and native joint septic arthritis. The oral antibiotics most frequently used for OAIs included trimethoprim-sulfamethoxazole, doxycycline\/minocycline, and linezolid for Staphylococcus aureus, amoxicillin\/cefadroxil\/cephalexin for streptococci, and fluoroquinolones for gram-negative organisms. The most common rationales for not transitioning to oral antibiotics included nonsusceptible pathogens, comorbidities preventing therapeutic drug levels, and concerns about adherence. SAT use was variable but employed by a majority in most cases of periprosthetic joint infection managed with debridement and implant retention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>North American ID physicians utilize oral antibiotics and SAT for the management of OAIs, although significant practice variation exists. Respondents voiced a need for updated guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofae280","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T16:42:52Z","timestamp":1715272972000},"source":"Crossref","is-referenced-by-count":15,"title":["Variation in North American Infectious Disease Specialists' Practice Regarding Oral and Suppressive Antibiotics for Adult Osteoarticular Infections: Results of an Emerging Infections Network (EIN) Survey"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6302-9471","authenticated-orcid":false,"given":"Nicol\u00e1s","family":"Cort\u00e9s-Penfield","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University of Nebraska Medical Center , Omaha, Nebraska , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Beekmann","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Carver College of Medicine University of Iowa , Iowa City, Iowa , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M","family":"Polgreen","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Carver College of Medicine University of Iowa , Iowa City, Iowa , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keenan","family":"Ryan","sequence":"additional","affiliation":[{"name":"Inpatient Pharmacy Department, University of New Mexico Hospital , Albuquerque, New Mexico , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Marschall","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Washington University School of Medicine , St. Louis, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poorani","family":"Sekar","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Carver College of Medicine University of Iowa , Iowa City, Iowa , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"2024062715574667300_ofae280-B1","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2106\/JBJS.N.01141","article-title":"Prevalence of total hip and knee replacement in the United States","volume":"97","author":"Maradit Kremers","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"2024062715574667300_ofae280-B2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"2024062715574667300_ofae280-B3","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2106\/JBJS.17.01617","article-title":"Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030","volume":"100","author":"Sloan","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"2024062715574667300_ofae280-B4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.arth.2007.10.017","article-title":"Infection burden for hip and knee arthroplasty in the United States","volume":"23","author":"Kurtz","year":"2008","journal-title":"J Arthroplasty"},{"key":"2024062715574667300_ofae280-B5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.idc.2018.06.005","article-title":"Prosthetic joint infection update","volume":"32","author":"Beam","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"2024062715574667300_ofae280-B6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jinf.2018.08.017","article-title":"Debridement, antibiotics and implant retention for periprosthetic joint infections: a systematic review and meta-analysis of treatment outcomes","volume":"77","author":"Kunutsor","year":"2018","journal-title":"J Infect"},{"key":"2024062715574667300_ofae280-B7","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2106\/JBJS.L.00789","article-title":"Periprosthetic joint infection increases the risk of one-year mortality","volume":"95","author":"Zmistowski","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"2024062715574667300_ofae280-B8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.diabet.2010.10.003","article-title":"Management of patients hospitalized for diabetic foot infection: results of the French OPIDIA study","volume":"37","author":"Richard","year":"2011","journal-title":"Diabetes Metab"},{"key":"2024062715574667300_ofae280-B9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13047-020-00383-2","article-title":"Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer","volume":"13","author":"Armstrong","year":"2020","journal-title":"J Foot Ankle Res"},{"key":"2024062715574667300_ofae280-B10","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/diagnostics12051289","article-title":"Fracture related infections and their risk factors for treatment failure\u2014a major trauma centre perspective","volume":"12","author":"Lu","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2024062715574667300_ofae280-B11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2024062715574667300_ofae280-B12","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa2020198","article-title":"Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection","volume":"384","author":"Bernard","year":"2021","journal-title":"N Engl J Med"},{"key":"2024062715574667300_ofae280-B13","doi-asserted-by":"crossref","first-page":"e1539","DOI":"10.1093\/cid\/ciaa1758","article-title":"Three weeks versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: a prospective, randomized, noninferiority pilot trial","volume":"73","author":"Gariani","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024062715574667300_ofae280-B14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/annrheumdis-2019-215116","article-title":"Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial","volume":"78","author":"Gjika","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024062715574667300_ofae280-B15","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/jac\/dkz202","article-title":"Four versus six weeks of antibiotic therapy for osteoarticular infections after implant removal: a randomized trial","volume":"74","author":"Benkabouche","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2024062715574667300_ofae280-B16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1302\/0301-620X.102B6.BJJ-2019-1596.R1","article-title":"2020 Mark Coventry Award: microorganism-directed oral antibiotics reduce the rate of failure due to further infection after two-stage revision hip or knee arthroplasty for chronic infection: a multicentre randomized controlled trial at a minimum of two years","volume":"102-B","author":"Yang","year":"2020","journal-title":"Bone Joint J"},{"key":"2024062715574667300_ofae280-B17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13018-020-01877-2","article-title":"Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial","volume":"15","author":"Karlsen","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"2024062715574667300_ofae280-B18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijantimicag.2012.10.023","article-title":"Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey","volume":"41","author":"Marschall","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"2024062715574667300_ofae280-B19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.diagmicrobio.2009.08.016","article-title":"Treatment approaches to prosthetic joint infections: results of an Emerging Infections Network survey","volume":"66","author":"Johannsson","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2024062715574667300_ofae280-B20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/cid\/ciz261","article-title":"Benefits and adverse events associated with extended antibiotic use in total knee arthroplasty periprosthetic joint infection","volume":"70","author":"Shah","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024062715574667300_ofae280-B21","doi-asserted-by":"crossref","first-page":"ofac363","DOI":"10.1093\/ofid\/ofac363","article-title":"Truth in DAIR: duration of therapy and the use of quinolone\/rifampin-based regimens after debridement and implant retention for periprosthetic joint infections","volume":"9","author":"Tai","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2024062715574667300_ofae280-B22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/cid\/ciad484","article-title":"How we approach suppressive antibiotic therapy following debridement, antibiotics, and implant retention for prosthetic joint infection","volume":"78","author":"Cortes-Penfield","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2024062715574667300_ofae280-B23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"key":"2024062715574667300_ofae280-B24","doi-asserted-by":"crossref","first-page":"e2582","DOI":"10.1093\/cid\/ciaa985","article-title":"Clinical experience of implementing oral versus intravenous antibiotics (OVIVA) in a specialist orthopedic hospital","volume":"73","author":"Azamgarhi","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae280\/57676176\/ofae280.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/6\/ofae280\/58216253\/ofae280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/6\/ofae280\/58216253\/ofae280.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T15:17:29Z","timestamp":1719501449000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae280\/7674053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae280","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,5,15]]},"article-number":"ofae280"}}